CELLREP
Summary of public USPTO data
- Owner
- CellRep Corporation
- Status
- Live/Registered
- Serial number
- 99213731
- Registration number
- 8319087
- Filing date
- 2025-06-02
- Registration date
- 2026-06-23
- International classes
- 42
Goods and services
Class 42
- Platform as a service (PAAS) featuring computer software platforms for for data analysis, drug discovery, drug screening, and preclinical testing in the field of bioinformatics
- Research and development in the field of bioinformatics
- Research and development in the field of cancer treatment and diagnosis
- Drug discovery services
- Drug screening for scientific research purposes
- Testing of pharmaceuticals for cell and gene therapies
- Research and development in the field of cell reprogramming technology for therapeutic applications
- Research and development in the field of epigenomic modification for cellular medicine
- Research and development in the field of enhancing cell and gene therapies
- Research and development in the field of immune cell enhancement and rejuvenation
- Research and development in the field of cell therapy enhancement for treatment of cancer, viral infections, and autoimmune disorders
- Research and development in the field of therapeutic kits and solutions for cellular medicine
- Platform as a service (PAAS) featuring computer software platforms for for enhancing cellular function and longevity
- Consulting services in the field of pharmaceutical research
- Consulting services in the field of biotechnology
- Consulting services in the field of genetic science